34
https://pubmed.ncbi.nlm.nih.gov/38115998
This correction clarifies that a meta-analysis found no significant association between changes in soluble PD-L1 levels and clinical outcomes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors.